Myocardial – Page 15 – Communicable Diseases Research

Myocarditis: imaging up to date

Cardiac Radiology

Published on 2020-10-062022-10-28
Journal: La Radiologia Medica [Category] Coronavirus, MERS, SARS,

Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies

Review

Published on 2020-09-162022-10-29
Journal: International Journal of Molecular Sciences [Category] COVID-19, SARS,

[키워드] accompanied acute respiratory syndrome adverse outcome angiotensin-converting enzyme 2 arrhythmia atherosclerotic plaques Blood clots cardiac event cardiac muscle cardiovascular cardiovascular complications cardiovascular diseases Clinical efficacy clinical trials Complication coronavirus disease COVID-19 COVID-19 patient COVID-19 patients death dysfunction elevated endothelial Evidence heart failure high risk highlight impairment include infected patients Infectious disease Inflammation Invasion mechanism multiple organ dysfunction Myocardial Myocardial infarction myocardial injury myocarditis outbreak oxygen supply pathophysiological mechanism Potential Prognosis reveal risk SARS-CoV-2 virus shown Strategy Stress Therapeutic approach therapeutic options thrombosis Treatment strategies with COVID-19 worldwide pandemic
[DOI] 10.3390/ijms21186790 PMC 바로가기 [Article Type] Review

Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial

Letter

Published on 2020-09-092022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 Ability Ability to walk Activation adhere administer ambulatory patient anatomical Anticoagulant treatment anticoagulation antiplatelet Atrial fibrillation baseline bleeding Blinding block size body temperature calculated Cardiovascular events characterized Chemotherapy clearance clinical benefit clinically Coagulation Coagulopathy Comorbidity Comparator group conducted contraindication control group coronary syndrome coronavirus cough COVID-19 creatinine criteria Critical current death defined diagnosed diagnosed with COVID-19 Diagnosis Disseminated intravascular coagulation dissemination dose Efficacy elderly element eligibility criteria eligible enoxaparin enrolment event event rate experimental group Face mask FIVE fixed heart failure help heparin-induced thrombocytopenia Hospitalization hospitals hygiene hypersensitivity impairment IMPROVE In-hospital Inflammation information injection inoperable Intervention intervention group invasive Ischemia Laboratory lack Last Liver disease lower limb major bleeding malignancy multicentre Myocardial number objective Older Open-label outcome parameter participant Participation Patient performed Platelet Positive test Presence prevention protocol provided Radiotherapy randomised randomised controlled trial randomization randomization ratio Randomized Randomized controlled trial receive reduce renal respiratory symptom resulting risk factor Sample size SARS-CoV2 secondary Seven Shortness of breath sore throat Spinal cord injury status Stratified randomization stroke Study protocol Support surgical survival symptomatic the patient therapy Thromboprophylaxis thrombosis total sample size Transport trauma Travel treated Treatment undergo university university hospital Venous Thromboembolism vessel viral disease VTE website
[DOI] 10.1186/s13063-020-04678-4 PMC 바로가기 [Article Type] Letter

Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection

Study Protocol

Published on 2020-09-032022-10-30
Journal: Journal of Cardiovascular Magnetic Resonance [Category] COVID-19,

[키워드] cardiac function Cardiac MRI cardiovascular CMR convalescent phase COVID-19 COVID-19 infection COVID-19 pandemic heart indication Myocardial pandemic Patient patients without COVID-19 performed protocol question recommendation recommendations resonance SARS-CoV-2 SCMR Society tissue
[DOI] 10.1186/s12968-020-00656-6 PMC 바로가기 [Article Type] Study Protocol

The Dual Role of Echocardiography in the Diagnosis of Acute Cardiac Complications and Treatment Monitoring for Coronavirus Disease 2019 (COVID-19)

Cardiovascular Medicine

Published on 2020-09-022022-10-31
Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19,

[키워드] acute coronary syndromes acute respiratory syndrome Analysis anti-inflammatory treatment antioxidant Antiviral Antiviral treatment Biomarker cardiac Cardiac complications cardiac function cardiovascular caused Complication consequence coronavirus Coronavirus disease 2019 COVID-19 deformation Diagnosis dysfunction Early detection ECG echocardiography Effect equipment Global longitudinal strain Healthcare system heart failure high-risk population identify intense investigation mandatory measure MONITOR monitoring Myocardial myocarditis novel Betacoronavirus operator pandemic Patient raise reported role SARS-CoV 2 Scientific community specific treatment transthoracic echo treatment regimen variety worse prognosis
[DOI] 10.3389/fcvm.2020.00129 PMC 바로가기 [Article Type] Cardiovascular Medicine

Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management

Research article

Published on 2020-09-012022-10-05
Journal: Heart Rhythm [Category] SARS, 바이오마커,

[키워드] amplification Arrhythmias Biomarkers cardiac damage cardiac function cardiovascular comorbidities changes in Clinical finding clinician Combination computed tomographic Coronary artery disease coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients Diagnosis Endomyocardial biopsy feasible fulminant myocarditis help host’s immune response Human identify Immunosuppression include Infection Inflammatory Injury interleukin 6 magnetic resonance imaging majority management mild cases Myocardial Myocardial infarction myocarditis pathophysiology remains uncertain reported risk SARS-CoV-2 thought Treatment viral genome
[DOI] 10.1016/j.hrthm.2020.05.001 [Article Type] Research article

Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020

Covid Commentaries

Published on 2020-09-012022-10-30
Journal: Journal of Nuclear Medicine [Category] COVID-19,

Special Article – Acute myocardial injury in patients hospitalized with COVID-19 infection: A review

Review article

Published on 2020-09-012022-10-05
Journal: Progress in Cardiovascular Diseases [Category] SARS, 바이오마커,

[키워드] 1 angiotensin II receptor type 1 19 Coronavirus disease 2019 ACE2 expression ACEAngiotensin Converting Enzyme ACEIAngiotensin converting enzyme inhibitor ACSAcute coronary syndrome Acute coronary syndrome Affect affected analyses angiotensin converting enzyme Angiotensin converting enzyme inhibitor angiotensin receptor blocker ARBAngiotensin receptor blocker article AT1 angiotensin II receptor type 1 Biomarker Biomarkers can be used cardiac cardiac myocytes Cardiomyopathy cardiovascular cardiovascular system clinical complex interplay COVID-19 COVID-19 virus COVID19 Coronavirus disease 2019 criteria CVcardiovascular Cytokine storm Diagnosis effective elevated Elevation endothelial injury etiology global pandemic heart failure HFheart failure hypercoagulability hyperinflammation Hypoxemia ILInterleukin incidence include Infection Inflammation interleukin Intervention lung mechanism Microvascular thrombosis MImyocardial infarction monocyte Mortality Myocardial Myocardial infarction myocardial injury myocarditis organ organ systems pathologic Patient patients patients hospitalized patients with COVID-19 potential mechanism Prevalence Protective ranged reduce Regulation Respiratory failure resulting risk risk stratification rupture SARS-CoV-2 SARSSevere Acute Respiratory Syndrome Severe acute respiratory syndrome signaling pathway ST segment elevation myocardial infarction STEMIST segment elevation myocardial infarction Stress subsequent T-cell Therapies Treatment Trial type I with COVID-19
[DOI] 10.1016/j.pcad.2020.05.013 [Article Type] Review article

Reversible cardiac dysfunction in severe COVID‐19 infection, mechanisms and case report

중증 COVID-19 감염의 가역적 심장 기능 장애, 기전 및 사례 보고

Case Reports

Published on 2020-08-272022-09-12
Journal: Echocardiography (Mount Kisco, N.Y.) [Category] MERS, 진단,

Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-08-172022-10-29
Journal: Trials [Category] Coronavirus, MERS,

[키워드] 24 hour absolute reduction Administered administration AIFA airway allocation sequence Alpha Anticoagulant anticoagulant therapy Anticoagulant treatment approval Arm Aspergillus assigned assumption average bleeding bleeding event blinded Block randomisation block size BMI Brain Breastfeeding Candida checked childbearing age chronic clinical clinical condition clinically combined use conjunctival contributed corpus Corticosteroid COVID-19 criteria Critical Critically ill cytomegalovirus D-dimer level death defined Delay detect diagnostic discharge dissemination dosage drug dysfunction effective element eligible patient enoxaparin enrolled EudraCT exclusion criteria expected hematemesis hematoma heparin-induced thrombocytopenia Herpe high risk High-dose history hospital hospital discharge Hypothesis ICU ICU free day ICU Patients impairing Inclusion inclusion criteria indicated Infection initial Inpatient intensive care unit interval Intervention Intra-articular intramuscular intravenously invasive Invasive mechanical ventilation investigator Italian limit LMWH low molecular weight low-molecular weight heparin macroscopic major bleeding mechanical ventilation medical intervention Methylprednisolone Mortality mortality rate Myocardial Non-invasive non-invasive ventilation number objective occur ophthalmic organ dysfunction PaO parallel group participant Patient performed Pharyngeal swab Pneumonia positive positive pressure pregnancy test Presence Prophylactic prophylactic dose Prophylaxis protocol random randomisation randomised randomised controlled trial randomization Randomized Randomized controlled trial Randomly Ratio receive recent recruited recruitment Rectal Bleeding red blood cell reduce reducing Registered required risk of death Safety Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 pneumonia secondary secure severe disease sick significantly sodium status steroid stratified stroke study drug Study protocol subcutaneously surgical syndrome therapeutic therapeutic doses therapy Treatment treatment group unfractionated heparin Venous Thromboembolism ventilated patient Ventilation website Weighting Withdrawal women
[DOI] 10.1186/s13063-020-04645-z PMC 바로가기 [Article Type] Letter